“Over 200,000 women are diagnosed with breast cancer every year in the U.S. alone, and this kit can have a major impact on determining a more personalized course of treatment for these patients.  Our team is looking forward to building a startup to develop this technology and improve breast cancer treatment options for women around the world.”

- Brian Yu, Taxor Diagnostics

“The Challenge provided an unique and incredible opportunity to get involved in developing a life-saving breast cancer technology, and we’re excited to have put together such a strong team that will work hard to bring a product with multiple medical indications to market for the benefit of breast cancer patients worldwide.  We would like to thank everyone involved in the Challenge, especially CAI, the Avon Foundation, and Dr. Burg and her team at Clemson University. Finally, we want to extend a special thanks to Shafin Khan and his commercialization team at New Orleans BioInnovation Center for their continued support of our entrepreneurial efforts."

- Frank Glaser, Pectogen Therapeutics